S-18327

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameS-18327
Drug Alias NameS-18327
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D4 receptor agonistsAdrenergic receptors alpha-2 agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorAdrenergic receptors alpha-2Dopamine D4 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLes Laboratoires Servier
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A